Tucson Meds

WEED Inc. is a publicly traded, multinational cannabis organization dedicated to the development and application of strain and disease-specific cannabis and hemp-derived compounds for therapeutic use in humans and animals. The company operates as a holding entity with various subsidiaries and collaborative partners, focusing on acquiring and controlling intellectual properties related to cannabis-based products and establishing recognized brand names in both national and international markets. Through its subsidiaries, including Sangre BioSciences, WEED Australia Ltd., and WEED Israel Cannabis Ltd., the company is engaged in extensive research and development initiatives, such as a comprehensive Cannabis Genome Study and exclusive licensing agreements for innovative cannabinoid formulations. WEED Inc. aims to leverage its expertise and resources to produce, market, and distribute a wide range of medical therapies and products derived from the Cannabaceae plant family. Generated from the website